Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Arani Casillas-Ramirez"'
Autor:
Carmen Peralta, Arani Casillas-Ramirez
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/78a2dec66cec41d8ab0c1d6940773229
Autor:
Cindy G. Avalos-de León, Mónica B. Jiménez-Castro, María Eugenia Cornide-Petronio, José Gulfo, Floriana Rotondo, Jordi Gracia-Sancho, Araní Casillas-Ramírez, Carmen Peralta
Publikováno v:
Cells, Vol 13, Iss 13, p 1139 (2024)
In the original publication [...]
Externí odkaz:
https://doaj.org/article/e37e389982de4e86a1ae52c7ec7684d2
Autor:
Araní Casillas-Ramírez, Marc Micó-Carnero, Alfredo Sánchez-González, Cristina Maroto-Serrat, Andrés Trostchansky, Carmen Peralta
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionBrain death (BD) and steatosis are both risk factors for organ dysfunction or failure in liver transplantation (LT)Material and methodsHere, we examine the role of interleukin 6 (IL- 6) and IL-10 in LT of both non-steatotic and steatotic
Externí odkaz:
https://doaj.org/article/8e114d05f7c641db9a288c2e66c2d7c3
Autor:
Monica B, Jimenez-Castro, Arani, Casillas-Ramirez, Marta, Massip-Salcedo, Maria, Elias-Miro, Anna, Serafin, Antoni, Rimola, Juan, Rodes, Carmen, Peralta
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 17(9)
Numerous steatotic livers are discarded as unsuitable for transplantation (TR) because of their poor tolerance of ischemia/reperfusion (I/R). Cyclic adenosine 3',5'-monophosphate (cAMP)-elevating agents protect against I/R injury both in nonsteatotic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44432010d9ce1bab732777f84ebd5157
https://pubmed.ncbi.nlm.nih.gov/21671350
https://pubmed.ncbi.nlm.nih.gov/21671350
Autor:
Ana Isabel Álvarez-Mercado, Carlos Rojano-Alfonso, Marc Micó-Carnero, Albert Caballeria-Casals, Carmen Peralta, Araní Casillas-Ramírez
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Visceral obesity is an important component of metabolic syndrome, a cluster of diseases that also includes diabetes and insulin resistance. A combination of these metabolic disorders damages liver function, which manifests as non-alcoholic fatty live
Externí odkaz:
https://doaj.org/article/19c1934b7e4a43d7b5f858781e5de370
The Role of Neuregulin-1 in Steatotic and Non-Steatotic Liver Transplantation from Brain-Dead Donors
Autor:
Marc Micó-Carnero, Araní Casillas-Ramírez, Alfredo Sánchez-González, Carlos Rojano-Alfonso, Carmen Peralta
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 978 (2022)
Background. Brain death (BD) and steatosis are key risk factors to predict adverse post-transplant outcomes. We investigated the role of Neuregulin-1 (NRG1) in rat steatotic and non-steatotic liver transplantation (LT) from brain death donors (DBD).
Externí odkaz:
https://doaj.org/article/29d718c16ef949799224281c9b1d32a2
Publikováno v:
Gastroenterology. 124:A741
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ad363a359ce4e3424feb8a34a842f42
https://doi.org/10.1016/s0016-5085(03)83743-5
https://doi.org/10.1016/s0016-5085(03)83743-5
Autor:
Ana I. Álvarez-Mercado, Albert Caballeria-Casals, Carlos Rojano-Alfonso, Jesús Chávez-Reyes, Marc Micó-Carnero, Alfredo Sanchez-Gonzalez, Araní Casillas-Ramírez, Jordi Gracia-Sancho, Carmen Peralta
Publikováno v:
Biomedicines, Vol 9, Iss 9, p 1158 (2021)
Hepatocellular carcinoma has become a leading cause of cancer-associated mortality throughout the world, and is of great concern. Currently used chemotherapeutic drugs in the treatment of hepatocellular carcinoma lead to severe side effects, thus und
Externí odkaz:
https://doaj.org/article/c5d15377669d4e269b7f7c8618024311
Autor:
Albert Caballeria-Casals, Marc Micó-Carnero, Carlos Rojano-Alfonso, Cristina Maroto-Serrat, Araní Casillas-Ramírez, Ana I. Álvarez-Mercado, Jordi Gracia-Sancho, Carmen Peralta
Publikováno v:
Cells, Vol 10, Iss 6, p 1421 (2021)
The pro-tumorigenic activity of fibroblast growth factor (FGF) 19 (FGF15 in its rodent orthologue) in hepatocellular carcinoma (HCC), as well as the unsolved problem that ischemia-reperfusion (IR) injury supposes in liver surgeries, are well known. H
Externí odkaz:
https://doaj.org/article/a19df0cad1634d478e2a7ae907c9ec17